AGT™ welcomes additional support of its HIV Cure clinical trial and broad gene therapy development platform American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, announced today that angel investor Ride Wave Ventures has made its first investment in the company.   Ride…

“The Cure Chronicles” presents thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working toward ending the HIV epidemic. American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, has launched a video series showcasing compelling HIV community conversations: The…

Maryland’s Biotechnology Investment Incentive Tax Credit (BIITC) program generates multiple benefits for the state American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, thanks the State of Maryland for its commitment to supporting biotech research through initiatives like the Biotechnology Investment Incentive Tax…

HIV cure clinical trial data shows safety and efficacy of AGT™ gene therapy treatment, the company will begin withdrawing participants from antiretrovirals in Q2 to test potential functional cure American Gene Technologies (AGT), a clinical-stage biotechnology company working to cure HIV, announced that the independent…

Data from a Total of Five Patients Demonstrates Critical Markers of the Company’s HIV Cure Gene & Cell Therapy American Gene Technologies, a clinical-stage biotechnology company working to cure HIV, announced that it has reached another important milestone for its HIV cure program. Five participants were…

Dr. Palin’s expertise in the intersection of business and technology strengthens AGT™ capability to bring patient solutions to the market. American Gene Technologies (AGT) announces the appointment of Dr. Drew Palin as business and strategy advisor to Jeff Galvin, CEO.   “I am excited to have…

Data from the First Three Patients Shows Critical Markers of the HIV Cure Cell Therapy: Engraftment, Persistence, and Function of Infused Cells American Gene Technologies (AGT™), a clinical-stage biotechnology company working to cure HIV, announced that it has reached two important milestones for its HIV cure…

American Gene Technologies (AGT), a clinical-stage biotechnology company, announced that the independent Data Safety and Monitoring Board (DSMB) overseeing the trial of AGT’s HIV gene therapy found no serious adverse events (SAEs) from the treatment for the third patient and voted unanimously to allow AGT’s HIV…

Dr. Conant, one of the first HIV/AIDS treatment pioneers, strengthens AGT’s capacity to progress toward a functional cure October 01, 2021 13:25 ET | Source:  American Gene Technologies American Gene Technologies (AGT) announces the appointment of Dr. Marcus A. Conant, a leading dermatologist in the U.S. and…

American Gene Technologies (AGT), a clinical-stage biotechnology company, announced that the independent Data Safety and Monitoring Board (DSMB) in charge of the trial safety found no serious adverse events (SAEs) from the treatment for the second patient and voted unanimously to allow AGT’s HIV cure program to…